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A 22-year-old woman with no history of autoim-
mune disease, inflammatory bowel disease, or ma-
lignancy presented to the emergency department
with well-demarcated erythema of both breasts, right
worse than left. Five days before she underwent
cosmetic bilateral augmentation mastopexy with
150-mL smooth round silicone gel implants and
suction-assisted lipectomy of the anterior and
posterior trunk and thighs, receiving appropriate
perioperative antibiotic prophylaxis with a first-
generation cephalosporin. Sites of liposuction were
not affected.
Erythema began on the third day after the
operation, advancing from the lower pole of each
breast to the inferior nipple progressing to wound
dehiscence and destruction, with bloody, purulent
drainage. Erythema was accompanied by fever
(40.58C), headache, increased C-reactive protein
level, elevated platelet level, and left-shift
leukocytosis. She had negative serologies for anti-
nuclear antibodies, anticytoplasmic neutrophil anti-
bodies and rheumatoid factor. Thyroid function tests
and serum glucose were within normal limits. She
underwent emergency surgery to remove both
implants, debridement and irrigation of necrotic
wounds with antibiotic solution, and placement of
bilateral drains; samples for culture were collected
(Fig 1).
Preliminary diagnosis was severe cellulitis and
acute breast implant infection after augmentation
mastopexy. Despite infectious disease consultation
and the commencement of vancomycin, daptomy-
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was rapid destruction on the lower pole of each
breast from the areola inferiorly with wound disrup-
tion and necrotic ulcerations. Fever continued (408C-
40.68C), and her condition did not improve. Culture
specimens were negative for bacteria, acid-fast
bacilli, and fungus. She was taken back to the
operating room to irrigate wounds with antibiotic
solution and placement of new drains; further
specimens were taken for culture and pathology.
Her condition continued to deteriorate.
Cultures remained sterile; pathologic tests found
acute and chronic inflammation with neutrophils,
fat necrosis, and stromal fibrosis. Because of her
declining state and failure to respond to antibiotics,
it was suspected that her condition was caused by
an autoimmune phenomenon. Subsequent admin-
istration of intravenous methylprednisolone over
the next 2 days caused improvement and halted
progress of the lesions. She underwent one last
debridement, irrigation with antibiotic solution,
and placement of new drains. Lack of response to
antibiotics, positive response with steroids, positive
pathologic findings, and negative culture sup-
ported the diagnosis of pyoderma gangrenosum
(PG).
Erythema and ulcerations continued to
improve with administration of steroids, there
was no further destruction of the skin, andJAAD Case Reports 2015;1:329-32.
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Fig 1. Pyoderma gangrenosum of the breast after bilateral mastopexy and liposuction. After
initial presentation in the emergency room, the patient underwent emergency surgery to
remove the silicone gel implants, debride necrotic tissue, irrigate with antibiotic solution, and
place drains. However, even when the patient was placed on broad-spectrum antibiotics and
antifungals, the wounds continued to show signs of necrosis and lacked signs of granulation
tissue.
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from the hospital 9 days after admission with
30 mg oral prednisone once daily for 7 days
followed by a 5-mg taper every 3 days with wet-
to-dry soaks daily. Three days after discharge,
drains were removed; at 6 days the patient’s left
breast wound sealed; and by 17 days, the right
breast defect closed.
The patient was seen by the dermatology
department, for the first time, 2 months later for
presumed early PG of the left perioareolar breast,
left areola, and the right outer breast. The patient
was prescribed triamcinolone acetonide 0.1%
topical cream applied twice a day 2 to 3 times a
week, and mupirocin 2% topical cream applied
twice daily to avoid secondary bacterial infection.
A month later, the reactive area decreased and was
limited to the left outer breast; the patient
continued taking mupirocin with the addition of
chlorhexidine 4% topical liquid to cleanse the
wound twice daily. Three months later, PG of the
left breast had resolved with a well-healed scar
(Fig 2).DISCUSSION
PG is an idiopathic, destructive inflammatory
disorder characterized by painful ulcerative lesions
with neutrophilic infiltration in response to
immune complex deposition.1-4 Histopathology
of full-thickness biopsies of lesions yields
nonspecific findings such as edema, follicular
pustules, necrosis, sterile dermal neutrophilia, mixed
inflammation, hemorrhage, and lymphocytic/
neutrophilic vasculitis1,2,5; wound cultures by
definition are sterile; however, they may be
contaminated by secondary infection.1,5 Often a
history suggesting pathergy, evidence of cribriform
scarring, lesion progression, failure to respond to
antibiotics, and response to systemic steroids are
clues for diagnosis.1
PG of the breast is not uncommon postsurgically;
it must be recognized early and treated appropriately
to avoid associated physical and psychological
morbidity (Fig 3). PG often affects breasts bilaterally
and symmetrically sparing the nipple-areola com-
plex, presumably because of differing histologic
characteristics. Differential diagnosis includes
Fig 2. Pyoderma gangrenosum resolution. The patient’s PG resolved over the course of
5 months: shown at 3 months (A) and 5.5 months (B and C) after treatment with triamcinolon
acetonide 0.1% topical cream, mupirocin 2% topical cream, and chlorhexidine 4% topical
liquid.
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itus, and systemic toxicity) and breast carcinoma.6
Although there has been no estimate on the inci-
dence of PG of the breast after surgery in the
literature, it is widely assumed that the rate is
significantly less than infection (estimated at 1%-
12% after reduction mammoplasty).7-9
Of the 32 cases of PG after breast surgery
reported to date, 17 have arisen from reduction
mammoplasty.10 It is unclear why pathergy is more
common in breast reduction, but it is thought that
decreased blood supply to hypertrophic breast
tissue, increased skin trauma during surgical
reconstruction, and growing incidence of surgery
all play a role.6 There is only one reported case of PG
after silicone implants in the breast.11 Silicone is an
unlikely source instigating PG; rather, the trauma to
the breast tissue during surgery causes a destructive,
inflammatory reaction. Although sample size is
small, trauma inflicted to the breast during surgery
plays a role in the amount of time it takes for PG to
develop; for instance, breast biopsies have 3 to
4 months between surgical insult and PG versus 4
to 42 days observed with reduction mammoplasty.6
PG treatment consists of 4 approaches: suppres-
sion of the exacerbating inflammation, promotinghealing, controlling pain, and treating the under-
lying cause (if such exists). First-line therapy
consists of systemic corticosteroids or cyclo-
sporine3,4; treatment with other immunosuppres-
sive drugs such as mycophenolate mofetil,
tacrolimus, dapsone, and azathioprine has also
been described in the literature.3,12 PG responds
well, almost immediately halting progression.
Unfortunately, lesions already present take weeks
to months to heal. Antibiotics such as mezlocillin,
rifampin, tetracycline, and vancomycin have been
used to prevent secondary bacterial superinfection
and modulate PG course secondarily as anti-in-
flammatories.3,4 There are reports of treating PG
with topical or intralesional injection of corticoste-
roids and other topical immunosuppressants.3 One
study used hydrocolloid dressing and allograft
installation; however, sample size was small, and
no further conclusions can be made at this time
regarding their use.3 Debridement is contraindi-
cated; if a patient does require further surgery, it is
suggested they be immunosuppressed and with-
out evidence of active disease to prevent recur-
rence.5,10 Treatment using antiseptic and dressings
combined with systemic immunosuppression is
advised for cases of PG.
Fig 3. Treatment flow for ulcerative, necrotic breast lesions after breast mammoplasty.
Although infection is a much more common adverse effect after breast surgery than PG, the
diagnosis of PG must still be on the forefront of surgeon’s and dermatologist’s minds when
patients present with necrotizing ulcerations. Cultures and biopsies must be performed
immediately to diagnose the lesion properly.
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